SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-023312
Filing Date
2017-10-03
Accepted
2017-10-03 17:00:26
Documents
2
Period of Report
2017-09-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2248
2 EX-24 DOCUMENT attachment1.htm EX-24 3562
  Complete submission text file 0000899243-17-023312.txt   7187
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address
Ray Sumita (Reporting) CIK: 0001579629 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36644 | Film No.: 171118845